title: The adenosinergic system in cancer: Key therapeutic target.
abstract: High amounts of adenosine are released in the tumor mass. Depending on the levels of adenosine, as well as on the receptor subtypes that are expressed by immune cells, adenosine can affect tumor growth in different fashions. Specifically targeting CD73, the rate-limiting enzyme for the extracellular generation of adenosine, or the A3 receptor offers new therapeutic strategies to limit tumor progression.
authors.affiliation: Department of Pharmaceutical and Biomedical Sciences; University of Salerno; Salerno, Italy.
authors.forename: Rosalinda
authors.initials: R
authors.lastname: Sorrentino
authors.forename: Aldo
authors.initials: A
authors.lastname: Pinto
authors.forename: Silvana
authors.initials: S
authors.lastname: Morello
keywords: ATP; CD73; adenosine; adenosine receptors; tumor immunity